Est. 2015 · United Kingdom · USA · Austria
AML-ALL-26
6th AnnualInvitation Only

AML-ALL

USFocus Meeting 2027
Three days, 74 people, one room.
July 8 to 10, 2027
San Diego, CA
Support Opportunities →
Dates
July 8-10, 2027
Three-day program
Venue
San Diego, CA
Hotel TBC
Audience
74 by invitation
37 KOLs & 37 fellows
Format
10 sessions · 40 talks
Plenary, panels + case sessions

A Curated Room: The People Shaping Practice

This sixth annual, invitation-only meeting convenes a deliberately small faculty: 37 leading acute leukemia KOLs alongside 37 hand-selected fellows and junior faculty, the clinicians defining today’s standards and the ones who will define the next decade’s, in one room for three days.

The science tracks where treatment is moving: menin inhibitors entering frontline combinations, FLT3 and IDH targeting across lines, HMA+VEN optimization, and bispecifics, ADCs and CAR-T reshaping relapsed and refractory disease. Every session pairs expert talks with a moderated panel, with case presentations threaded through both disease streams, sustained, close-quarters engagement rather than a lecture hall.

Menin InhibitorsFLT3 & IDH TargetingHMA+VEN OptimizationBispecifics, ADCs & CAR-TMRD-Guided StrategyAML · ALL · MDS
Meeting Co-Chairs
Listed alphabetically by surname
Naval Daver
Naval Daver
MD Anderson Cancer Center, Houston, TX
Elias-Jabbour
Elias Jabbour
MD Anderson Cancer Center, Houston, TX
Faculty Drawn From
MD Anderson · Memorial Sloan Kettering · Dana-Farber · Moffitt · City of Hope and other leading US cancer centers
74
Invited attendees only, sustained access, not a crowd
1:1
KOLs to rising faculty, a hand-picked balance in every session
21
Established meetings across the US and Europe, a proven platform
AML-ALL US Focus Meeting 2027

Confirmed Faculty

Listed alphabetically by surname
Hussein Abbas
MD Anderson Cancer Center, Houston, TX
Ibrahim Aldoss
City of Hope, Duarte, CA
Roberta Azevedo
MD Anderson Cancer Center, Houston, TX
Kelly Chien
MD Anderson Cancer Center, Houston, TX
Naval Daver
MD Anderson Cancer Center, Houston, TX
Courtney DiNardo
MD Anderson Cancer Center, Houston, TX
Ann-Kathrin Eisfeld
OSU Comprehensive Cancer Center, Columbus, OH
Amir Fathi
Massachusetts General Hospital, Boston, MA
Armin Ghobadi
Washington University School of Medicine, St. Louis, MO
Sergio Giralt
Memorial Sloan Kettering Cancer Center, New York, NY
Hannah Goulart
MD Anderson Cancer Center, Houston, TX
Fadi Haddad
MD Anderson Cancer Center, Houston, TX
Christopher Hourigan
Virginia Tech FBRI Cancer Research Center, Washington, DC
Elias Jabbour
MD Anderson Cancer Center, Houston, TX
Nitin Jain
MD Anderson Cancer Center, Houston, TX
Tapan Kadia
MD Anderson Cancer Center, Houston, TX
Hagop Kantarjian
MD Anderson Cancer Center, Houston, TX
Rami Komrokji
Moffitt Cancer Center, Tampa, FL
Aaron Logan
UCSF Health, San Francisco, CA
Sanam Loghavi
MD Anderson Cancer Center, Houston, TX
Marlise Luskin
Dana-Farber Cancer Institute, Boston, MA
Susan O'Brien
UCI Health, Orange, CA
Kristen O'Dwyer
University of Rochester Medical Center, Rochester, NY
Jae Park
Memorial Sloan Kettering Cancer Center, New York, NY
Naveen Pemmaraju
MD Anderson Cancer Center, Houston, TX
Alexander Perl
University of Pennsylvania, Philadelphia, PA
Gail J. Roboz
Weill Cornell Medicine, New York, NY
David Sallman
Moffitt Cancer Center, Tampa, FL
Roland Walter
Fred Hutchinson Cancer Center, Seattle, WA
Eunice Wang
Roswell Park Comprehensive Cancer Center, Buffalo, NY
Jun Yang
St. Jude Children's Research Hospital, Memphis, TN
Amer Zeidan
Yale School of Medicine, New Haven, CT
Joshua Zeidner
UNC School of Medicine, Chapel Hill, NC
Further faculty to be announced
Three Days, Ten Sessions

Proposed Agenda

Presentations15 min
Panel Discussions30 min
Lunch Break & Networking50 min
Day One · Thursday, July 8, 2027
Session ITBC
Moderator
Updates on CML
Hagop KantarjianMD Anderson Cancer Center, Houston, TX
Updates on CLL
Susan O'BrienUCI Health, Orange, CA
Updates on Low Risk MDS
Rami KomrokjiMoffitt Cancer Center, Tampa, FL
Panel Discussion
Session IITBC
Moderator
Updates on High Risk MDS
Speaker TBC
Updates on BPDCN
Naveen PemmarajuMD Anderson Cancer Center, Houston, TX
Case Presentations and Panel Discussion
Fadi Haddad (CML) and Kelly Chien (MDS)MD Anderson Cancer Center, Houston, TX
Panel Discussion & Take-Home Points From Day 1
Partnership Opportunities Now Open

Bespoke engagement packages for a closed, invitation-only audience

Request the Prospectus →
Zeynep Aydagül
Your Point of Contact
Zeynep Aydagül
Account Executive, MD Education